首页> 美国卫生研究院文献>Clinical and Translational Allergy >Component resolved diagnosis: when should it be used?
【2h】

Component resolved diagnosis: when should it be used?

机译:组件解析诊断:何时应使用?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The knowledge on molecular allergy diagnosis is continuously evolving. It is now time for the clinician to integrate this knowledge and use it when needed to improve the accuracy of diagnosis and thus provide more precise therapeutic and avoidance measures. This review does not intend to comprehensively analyze all the available allergen molecules, but to provide some practical clues on use and interpretation of molecular allergy diagnosis. The potential role of component resolved diagnosis in circumstances such as the indication of allergen immunotherapy, pollen polysensitization, food allergy, latex allergy or anaphylaxis, is assessed. Interpreting the information provided by molecular allergy diagnosis needs a structured approach. It is necessary to evaluate single positivities and negativities, but also to appraise “the big picture” with perspective.
机译:关于分子过敏诊断的知识在不断发展。现在是时候让临床医生整合这些知识,并在需要时使用它来提高诊断的准确性,从而提供更精确的治疗和避免措施。这篇综述并不是要全面分析所有可用的过敏原分子,而是要提供一些有关分子过敏诊断的使用和解释的实用线索。评估了在诸如变应原免疫疗法,花粉多敏化,食物过敏,乳胶过敏或过敏反应等情况下,成分分辨诊断的潜在作用。解释分子过敏诊断提供的信息需要一种结构化的方法。有必要评估单个的积极性和消极性,但也要用观点来评估“大局”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号